US3244592A
(en)
*
|
1962-06-09 |
1966-04-05 |
Arai Tadashi |
Ascomycin and process for its production
|
US4039662A
(en)
|
1975-12-04 |
1977-08-02 |
Alcon Laboratories, Inc. |
Ophthalmic solution
|
US4117118A
(en)
|
1976-04-09 |
1978-09-26 |
Sandoz Ltd. |
Organic compounds
|
US4120949A
(en)
|
1977-10-05 |
1978-10-17 |
Cooper Laboratories, Inc. |
Ophthalmic solution
|
US4409205A
(en)
|
1979-03-05 |
1983-10-11 |
Cooper Laboratories, Inc. |
Ophthalmic solution
|
US5209927A
(en)
*
|
1985-01-23 |
1993-05-11 |
Alcon Laboratories, Inc. |
Ophthalmic solution
|
US4649047A
(en)
*
|
1985-03-19 |
1987-03-10 |
University Of Georgia Research Foundation, Inc. |
Ophthalmic treatment by topical administration of cyclosporin
|
US4744980A
(en)
*
|
1986-04-28 |
1988-05-17 |
Holly Frank J |
Ophthalmic solution for treatment of dry eye syndrome
|
US4883658A
(en)
|
1986-04-28 |
1989-11-28 |
Holly Frank J |
Ophthalmic solution for treatment of dry-eye syndrome
|
US4804539A
(en)
*
|
1986-07-28 |
1989-02-14 |
Liposome Technology, Inc. |
Ophthalmic liposomes
|
CH668553A5
(de)
*
|
1987-02-02 |
1989-01-13 |
Mepha Ag |
Arzneimittel mit verzoegerter wirkstofffreisetzung.
|
JP2577049B2
(ja)
|
1987-06-04 |
1997-01-29 |
三共株式会社 |
シクロスポリン製剤
|
ATE109970T1
(de)
*
|
1987-09-03 |
1994-09-15 |
Univ Georgia Res Found |
Cyclosporin-augenmittel.
|
US4839342A
(en)
*
|
1987-09-03 |
1989-06-13 |
University Of Georgia Research Foundation, Inc. |
Method of increasing tear production by topical administration of cyclosporin
|
US5110493A
(en)
*
|
1987-09-11 |
1992-05-05 |
Syntex (U.S.A.) Inc. |
Ophthalmic NSAID formulations containing a quaternary ammonium preservative and a nonionic surfactant
|
US5414011A
(en)
*
|
1987-09-11 |
1995-05-09 |
Syntex (U.S.A.) Inc. |
Preservative system for ophthalmic formulations
|
US5188826A
(en)
*
|
1988-02-08 |
1993-02-23 |
Insite Vision Incorporated |
Topical ophthalmic suspensions
|
US4865846A
(en)
|
1988-06-03 |
1989-09-12 |
Kaufman Herbert E |
Drug delivery system
|
DE68921934T2
(de)
|
1988-06-29 |
1995-10-19 |
Merck & Co Inc |
Immunsuppressives Agens.
|
US5607698A
(en)
*
|
1988-08-04 |
1997-03-04 |
Ciba-Geigy Corporation |
Method of preserving ophthalmic solution and compositions therefor
|
US6007840A
(en)
|
1988-09-16 |
1999-12-28 |
Novartis Ag |
Pharmaceutical compositions comprising cyclosporins
|
KR0148748B1
(ko)
|
1988-09-16 |
1998-08-17 |
장 크라메르, 한스 루돌프 하우스 |
사이클로스포린을 함유하는 약학조성물
|
US5342625A
(en)
|
1988-09-16 |
1994-08-30 |
Sandoz Ltd. |
Pharmaceutical compositions comprising cyclosporins
|
US5360611A
(en)
|
1988-10-03 |
1994-11-01 |
Alcon Laboratories, Inc. |
Pharmaceutical compositions and methods of treatment of the cornea following ultraviolet laser irradiation
|
US5540931A
(en)
|
1989-03-03 |
1996-07-30 |
Charles W. Hewitt |
Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
|
US5075104A
(en)
|
1989-03-31 |
1991-12-24 |
Alcon Laboratories, Inc. |
Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
|
FR2657018A1
(fr)
|
1990-01-12 |
1991-07-19 |
Merck Sharp & Dohme |
Composition ophtalmique fluide a base de microparticules lipidiques contenant au moins un principe actif et son procede de preparation.
|
US5227372A
(en)
*
|
1990-03-07 |
1993-07-13 |
Children's Medical Center Corporation |
Method for retaining ophthalmological agents in ocular tissues
|
US5252318A
(en)
|
1990-06-15 |
1993-10-12 |
Allergan, Inc. |
Reversible gelation compositions and methods of use
|
US6165500A
(en)
|
1990-08-24 |
2000-12-26 |
Idea Ag |
Preparation for the application of agents in mini-droplets
|
ATE126694T1
(de)
*
|
1990-11-19 |
1995-09-15 |
Nat Starch Chem Invest |
Entzweigte stärken enthaltende kosmetische mittel.
|
TW209174B
(es)
|
1991-04-19 |
1993-07-11 |
Takeda Pharm Industry Co Ltd |
|
IL102414A
(en)
*
|
1991-07-25 |
1996-08-04 |
Univ Louisville Res Found |
Medicinal preparations for the treatment of ocular inflammation, containing rapamycin
|
US5252246A
(en)
|
1992-01-10 |
1993-10-12 |
Allergan, Inc. |
Nonirritating nonionic surfactant compositions
|
GB9204466D0
(en)
|
1992-03-02 |
1992-04-15 |
Sandoz Ltd |
Improvements in or relating to organic compounds
|
US5830508A
(en)
|
1992-08-06 |
1998-11-03 |
Deo Corporation |
Composition for treating dry eye
|
NZ247516A
(en)
|
1993-04-28 |
1995-02-24 |
Bernard Charles Sherman |
Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant
|
CA2125060C
(en)
*
|
1993-07-02 |
1999-03-30 |
Henry P. Dabrowski |
Ophthalmic solution for artificial tears
|
US5624893A
(en)
*
|
1993-10-14 |
1997-04-29 |
Alcon Laboratories, Inc. |
Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation
|
WO1995030420A1
(en)
*
|
1994-05-06 |
1995-11-16 |
Alcon Laboratories, Inc. |
Use of vitamin e tocopheryl derivatives in ophthalmic compositions
|
GB9409778D0
(en)
*
|
1994-05-16 |
1994-07-06 |
Dumex Ltd As |
Compositions
|
US5474979A
(en)
|
1994-05-17 |
1995-12-12 |
Allergan, Inc. |
Nonirritating emulsions for sensitive tissue
|
US6309630B1
(en)
|
1994-05-24 |
2001-10-30 |
Insite Vision Incorporated |
Non-steroidal anti-inflammatory ophthalmic suspensions
|
GB9412273D0
(en)
*
|
1994-06-18 |
1994-08-10 |
Univ Nottingham |
Administration means
|
IT1273011B
(it)
*
|
1994-07-25 |
1997-07-01 |
Trhecnopharma S A |
Preparato oftalmico per l'uso come lacrima artificiale
|
US5698533A
(en)
|
1994-07-26 |
1997-12-16 |
Kang; Meng-Che |
Ophthalmic pharmaceutical composition
|
ES2094688B1
(es)
|
1994-08-08 |
1997-08-01 |
Cusi Lab |
Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
|
US5599534A
(en)
*
|
1994-08-09 |
1997-02-04 |
University Of Nebraska |
Reversible gel-forming composition for sustained delivery of bio-affecting substances, and method of use
|
US5603929A
(en)
|
1994-11-16 |
1997-02-18 |
Alcon Laboratories, Inc. |
Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds
|
US5558876A
(en)
|
1995-03-29 |
1996-09-24 |
Alcon Laboratories, Inc. |
Topical ophthalmic acidic drug formulations
|
US20060280774A1
(en)
|
1995-06-02 |
2006-12-14 |
Allergan, Inc. |
Compositions and methods for treating glaucoma
|
US5869079A
(en)
*
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
US5773019A
(en)
*
|
1995-09-27 |
1998-06-30 |
The University Of Kentucky Research Foundation |
Implantable controlled release device to deliver drugs directly to an internal portion of the body
|
NZ280689A
(en)
|
1995-12-15 |
1997-08-22 |
Bernard Charles Sherma Sherman |
Pharmaceutical composition comprising a cyclosporipharmaceutical composition comprising a cyclosporin; a tocol, tocopherol or tocotrienol; and propylen; a tocol, tocopherol or tocotrienol; and propylene carbonate or polyethylene glycol ne carbonate or polyethylene glycol
|
US5798333A
(en)
|
1996-09-17 |
1998-08-25 |
Sherman; Bernard C. |
Water-soluble concentrates containing cyclosporins
|
US5814655A
(en)
|
1996-11-14 |
1998-09-29 |
Insite Vision Incorporated |
Non-steroidal ophthalmic mixtures
|
US6458373B1
(en)
*
|
1997-01-07 |
2002-10-01 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
MX9701946A
(es)
|
1997-03-14 |
1998-04-30 |
Arturo Jimenez Bayardo |
Solucion oftalmica transportadora.
|
GB9810236D0
(en)
|
1998-05-13 |
1998-07-08 |
Microbiological Res Authority |
Improvements relating to encapsulation of bioactive agents
|
US6406719B1
(en)
*
|
1998-05-13 |
2002-06-18 |
Microbiological Research Authority |
Encapsulation of bioactive agents
|
AU769429C
(en)
|
1998-12-30 |
2004-10-28 |
Dexcel Limited |
Dispersible concentrate for the delivery of cyclosporin
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
US6217895B1
(en)
*
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US6254860B1
(en)
|
1999-04-13 |
2001-07-03 |
Allergan Sales, Inc. |
Ocular treatment using cyclosporin-A derivatives
|
US6531128B1
(en)
|
2000-02-08 |
2003-03-11 |
Pharmacia Corporation |
Methods for treating glaucoma
|
US6284235B1
(en)
|
2000-02-11 |
2001-09-04 |
National Starch And Chemical Company Investment Holding Corporation |
Bioadhesive composition
|
US20030018044A1
(en)
*
|
2000-02-18 |
2003-01-23 |
Peyman Gholam A. |
Treatment of ocular disease
|
PT1142566E
(pt)
*
|
2000-04-07 |
2004-02-27 |
Medidom Lab |
Formulacao oftalmica topica na forma de uma solucao aquosa e uso de uma ciclosporina em associacao com acido hialuronico ou um de seus sais e com polisorbato 80
|
PT1299348E
(pt)
*
|
2000-06-29 |
2008-05-12 |
Emisphere Tech Inc |
Compostos e composições para administração de agentes activos
|
AU9489801A
(en)
|
2000-09-28 |
2002-04-08 |
Chiron Corp |
Microparticle compositions and methods for the manufacture thereof
|
AU2002236495B2
(en)
|
2000-11-29 |
2006-05-11 |
Allergan, Inc. |
Intraocular implants for preventing transplant rejection in the eye
|
US20030072737A1
(en)
*
|
2000-12-29 |
2003-04-17 |
Michael Brines |
Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
|
US6784156B2
(en)
*
|
2001-03-05 |
2004-08-31 |
Enanta Pharmaceuticals, Inc. |
Cyclosporins for the treatment of respiratory diseases
|
US6713081B2
(en)
*
|
2001-03-15 |
2004-03-30 |
The United States Of America As Represented By The Department Of Health And Human Services |
Ocular therapeutic agent delivery devices and methods for making and using such devices
|
US6872382B1
(en)
*
|
2001-05-21 |
2005-03-29 |
Alcon, Inc. |
Use of selective PDE IV inhibitors to treat dry eye disorders
|
JP2005502621A
(ja)
*
|
2001-07-06 |
2005-01-27 |
スキャンポ アーゲー |
インターロイキン2阻害剤および抗菌剤を含む局所投与用組成物
|
US6809077B2
(en)
|
2001-10-12 |
2004-10-26 |
Enanta Pharmaceuticals, Inc. |
Cyclosporin analogs for the treatment of autoimmune diseases
|
US20030087813A1
(en)
|
2001-10-12 |
2003-05-08 |
Or Yat Sun |
Cyclosporin analogs for the treatment of lung diseases
|
AR036853A1
(es)
|
2001-10-19 |
2004-10-06 |
Isotechnika Inc |
Mezclas de analogos de ciclosporina y su uso como agentes inmunomoduladores.
|
KR100982466B1
(ko)
|
2001-10-19 |
2010-09-16 |
이소테크니카 인코포레이티드 |
시클로스포린 유사체의 합성
|
ES2330625T3
(es)
|
2001-10-19 |
2009-12-14 |
Isotechnika Inc. |
Preconcentrados de microemulsion de analogos de ciclosporina novedosos.
|
US7001615B1
(en)
*
|
2001-12-07 |
2006-02-21 |
Alcon, Inc. |
Sustained release ophthalmic, otic and nasal suspension
|
MXPA01013257A
(es)
|
2001-12-18 |
2003-06-25 |
Arturo Jimenez Bayardo |
Suspension oftalmica de rofecoxib para el tratamiento de la inflamacion y el dolor ocular.
|
US20030165545A1
(en)
|
2002-01-30 |
2003-09-04 |
Allergan, Inc. |
Ophthalmic compositions including oil-in-water emulsions, and methods for making and using same
|
US7846478B2
(en)
|
2002-01-31 |
2010-12-07 |
Henkel Ag & Co. Kgaa |
Bioadhesive composition
|
JP4679822B2
(ja)
|
2002-03-13 |
2011-05-11 |
ノバルティス アーゲー |
医薬微粒子
|
US6828356B2
(en)
|
2002-07-29 |
2004-12-07 |
Ast Products, Inc. |
Preparation of ophthalmic compositions
|
US20040110666A1
(en)
*
|
2002-12-04 |
2004-06-10 |
Or Yat Sun |
Cyclosporins for the treatment of immune disorders
|
MXJL02000046A
(es)
*
|
2002-12-13 |
2004-06-24 |
Jimenez Bayardo Arturo |
Solucion inyectable intravitrea para el tratamiento de hemorragias vitreas.
|
US20060177430A1
(en)
|
2002-12-20 |
2006-08-10 |
Chakshu Research Inc |
Treatment of ocular disorders with ophthalmic formulations containing methylsulfonylmethane as a transport enhancer
|
US7012065B2
(en)
*
|
2003-02-07 |
2006-03-14 |
Enanta Pharmaceuticals, Inc. |
Cyclosporins for the treatment of immune disorders
|
TW200505946A
(en)
|
2003-04-08 |
2005-02-16 |
Hoffmann La Roche |
Process for preparation of cyclosporin a analog
|
WO2004096261A1
(es)
|
2003-05-02 |
2004-11-11 |
Arturo Jimenez Bayardo |
Metodo para preparar una solucion acuosa de ciclosporina-a y solucion acuosa resultante
|
EP1623722B1
(en)
*
|
2003-05-15 |
2010-06-23 |
Menicon Co., Ltd. |
Composition for ophthalmic use
|
US20070043006A1
(en)
*
|
2003-06-13 |
2007-02-22 |
Bingaman David P |
Formulations of non-steroidal anti-inflammatory agents to treat pathologic ocular angiogenesis
|
US20040266669A1
(en)
|
2003-06-20 |
2004-12-30 |
Wu Frank X. H. |
Cyclosporin derivatives for the treatment of immune disorders
|
WO2005004876A1
(es)
*
|
2003-07-10 |
2005-01-20 |
Arturo Jimenez Bayardo |
Metodo para preparar una solucion acuosa de meloxicam y solucion acuosa resultante
|
BRPI0412059A
(pt)
|
2003-07-15 |
2006-09-05 |
Pr Pharmaceuticals Inc |
método para a preparação de formulação de liberação controlada
|
US6984628B2
(en)
*
|
2003-07-15 |
2006-01-10 |
Allergan, Inc. |
Ophthalmic compositions comprising trefoil factor family peptides
|
ES2593113T3
(es)
*
|
2003-08-07 |
2016-12-05 |
Allergan, Inc. |
Composiciones para el suministro de agentes terapéuticos en los ojos y métodos para obtener y usar los mismos
|
US20050059583A1
(en)
|
2003-09-15 |
2005-03-17 |
Allergan, Inc. |
Methods of providing therapeutic effects using cyclosporin components
|
US7087237B2
(en)
*
|
2003-09-19 |
2006-08-08 |
Advanced Ocular Systems Limited |
Ocular solutions
|
US20050181018A1
(en)
|
2003-09-19 |
2005-08-18 |
Peyman Gholam A. |
Ocular drug delivery
|
US7083803B2
(en)
*
|
2003-09-19 |
2006-08-01 |
Advanced Ocular Systems Limited |
Ocular solutions
|
TW200517114A
(en)
*
|
2003-10-15 |
2005-06-01 |
Combinatorx Inc |
Methods and reagents for the treatment of immunoinflammatory disorders
|
SI1759702T1
(sl)
*
|
2004-05-26 |
2009-06-30 |
Bayardo Arturo Jimenez |
Postopek pripravljanja oftalmiäśne raztopine latanoprosta in tako proizvedena raztopina
|
US8372814B2
(en)
|
2004-06-07 |
2013-02-12 |
Ista Pharmaceuticals, Inc. |
Ophthalmic formulations and uses thereof
|
US20050277584A1
(en)
|
2004-06-09 |
2005-12-15 |
Allergan, Inc. |
Pharmaceutical compositions comprising cyclosporins
|
WO2006014484A2
(en)
*
|
2004-07-02 |
2006-02-09 |
Surmodics, Inc. |
Methods and devices for the treatment of ocular conditions
|
WO2006028361A1
(es)
|
2004-09-09 |
2006-03-16 |
Arturo Jimenez Bayardo |
Implantes y microesferas de liberación prolongada de fármacos de uso oftálmico y metodos para prepararlos
|
EP1799194B1
(en)
|
2004-09-24 |
2011-11-16 |
Boehringer Ingelheim Pharmaceuticals Inc. |
A new class of surfactant-like materials comprising vitamin e tpgs and a water soluble polymer
|
US7511013B2
(en)
*
|
2004-09-29 |
2009-03-31 |
Amr Technology, Inc. |
Cyclosporin analogues and their pharmaceutical uses
|
US7378391B2
(en)
|
2004-09-29 |
2008-05-27 |
Amr Technology, Inc. |
Cyclosporin alkyne analogues and their pharmaceutical uses
|
JP2008515886A
(ja)
|
2004-10-06 |
2008-05-15 |
エーエムアール テクノロジー インコーポレイテッド |
シクロスポリンアルキンおよびそれらの医用薬剤としての有用性
|
US7214664B2
(en)
*
|
2004-12-03 |
2007-05-08 |
The Curators Of The University Of Missouri |
Peptidyl prodrugs that resist P-glycoprotein mediated drug efflux
|
US20060148686A1
(en)
|
2004-12-30 |
2006-07-06 |
Bausch & Lomb Incorporated |
Ophthalmic compositions comprising steroid and cyclosporine for dry eye therapy
|
DK1848431T3
(en)
|
2005-02-09 |
2016-04-18 |
Santen Pharmaceutical Co Ltd |
LIQUID FORMULATIONS FOR TREATMENT OF DISEASES OR CONDITIONS
|
US20060204548A1
(en)
|
2005-03-01 |
2006-09-14 |
Allergan, Inc. |
Microimplants for ocular administration
|
BRPI0609432A2
(pt)
|
2005-03-21 |
2010-04-06 |
Macusight Inc |
sistemas de distribuição de fármacos para tratamento de doenças ou condições
|
US8003124B2
(en)
|
2005-04-08 |
2011-08-23 |
Surmodics, Inc. |
Sustained release implants and methods for subretinal delivery of bioactive agents to treat or prevent retinal disease
|
US7202209B2
(en)
*
|
2005-07-13 |
2007-04-10 |
Allergan, Inc. |
Cyclosporin compositions
|
US7297679B2
(en)
*
|
2005-07-13 |
2007-11-20 |
Allergan, Inc. |
Cyclosporin compositions
|
US20070015691A1
(en)
*
|
2005-07-13 |
2007-01-18 |
Allergan, Inc. |
Cyclosporin compositions
|
US7288520B2
(en)
|
2005-07-13 |
2007-10-30 |
Allergan, Inc. |
Cyclosporin compositions
|
US20070015693A1
(en)
*
|
2005-07-13 |
2007-01-18 |
Allergan, Inc. |
Cyclosporin compositions
|
US8288348B2
(en)
|
2005-07-13 |
2012-10-16 |
Allergan, Inc. |
Cyclosporin compositions
|
US7276476B2
(en)
|
2005-07-13 |
2007-10-02 |
Allergan, Inc. |
Cyclosporin compositions
|
CA2615990A1
(en)
*
|
2005-07-18 |
2007-01-25 |
Minu, L.L.C. |
Enhanced ocular neuroprotection/neurostimulation
|
US7893040B2
(en)
*
|
2005-07-22 |
2011-02-22 |
Oculis Ehf |
Cyclodextrin nanotechnology for ophthalmic drug delivery
|
US7501393B2
(en)
*
|
2005-07-27 |
2009-03-10 |
Allergan, Inc. |
Pharmaceutical compositions comprising cyclosporins
|
US7745400B2
(en)
|
2005-10-14 |
2010-06-29 |
Gregg Feinerman |
Prevention and treatment of ocular side effects with a cyclosporin
|
US20070087962A1
(en)
*
|
2005-10-17 |
2007-04-19 |
Allergan, Inc. |
Pharmaceutical compositions comprising cyclosporins
|
ZA200804550B
(en)
*
|
2005-11-09 |
2009-08-26 |
Combinatorx Inc |
Methods, compositions, and kits for the treatment of medical conditions
|
US7544371B2
(en)
*
|
2005-12-20 |
2009-06-09 |
Bausch + Lomb Incorporated |
Drug delivery systems
|
US7655625B2
(en)
*
|
2006-02-13 |
2010-02-02 |
Allergan, Inc. |
Methods of treating blepharospasm using cyclosporine components
|
US7557082B2
(en)
|
2006-03-03 |
2009-07-07 |
Allergan, Inc. |
Treatment with cyclosporin A
|
US20070219127A1
(en)
|
2006-03-20 |
2007-09-20 |
Walt John G |
Cyclosporin a compositions
|
WO2008002118A1
(es)
|
2006-06-27 |
2008-01-03 |
Arturo Jimenez Bayardo |
Una formulación oftálmica en suspensión de etabonato de loteprednol y clorhidrato de ciprofloxacina
|
US20080146497A1
(en)
*
|
2006-07-25 |
2008-06-19 |
Graham Richard S |
Cyclosporin Compositions
|
US9561178B2
(en)
*
|
2006-07-25 |
2017-02-07 |
Allergan, Inc. |
Cyclosporin compositions
|
US8435544B2
(en)
|
2007-10-08 |
2013-05-07 |
Lux Biosciences, Inc. |
Ophthalmic compositions comprising calcineurin inhibitors or mTOR inhibitors
|
US20090196905A1
(en)
|
2008-02-06 |
2009-08-06 |
Spada Lon T |
Stabilization of mitochondrial membranes in ocular diseases and conditions
|
US9017725B2
(en)
*
|
2009-06-09 |
2015-04-28 |
Aurinia Pharmaceuticals Inc. |
Topical drug delivery systems for ophthalmic use
|